# 🔺 Hyperphosphatemia

## 🔬 Calcium-Phosphate Homeostasis Overview

**Understanding the System:** Hyperphosphatemia disrupts calcium homeostasis through calcium-phosphate precipitation. The kidneys (red) normally excrete 85-90% of dietary phosphate. Loss of renal function is the primary cause of hyperphosphatemia. FGF23 rises early in CKD to maintain phosphate balance.

## 🚨 EMERGENCY PROTOCOL: Severe Hyperphosphatemia with Hypocalcemia

1 **Treat Hypocalcemia First:** IV calcium gluconate if symptomatic 2 **Volume Expansion:** NS + loop diuretics if preserved renal function 3 **Emergency Dialysis:** For severe cases, renal failure, or TLS 4 **Phosphate Binders:** Start immediately with meals 5 **Monitor Ca × PO₄ Product:** Keep \<55 to prevent precipitation

**⚠️ Critical:** Ca × PO₄ \>70 → Tissue calcification risk!

## 📊 Definition and Clinical Consequences

### Acute vs Chronic Effects

#### Acute Effects

- Calcium-phosphate precipitation
- Acute hypocalcemia
- Tetany, seizures
- Soft tissue calcification
- Acute kidney injury

#### Chronic Effects (CKD)

- Vascular calcification
- ↑Cardiovascular mortality (18-35% per 1 mg/dL)
- Secondary hyperparathyroidism
- Renal osteodystrophy
- Calciphylaxis (rare but severe)

## 🔍 Phosphate Retention in CKD Stages

#### Stage 1-2

GFR \>60

**Normal PO₄**

↑FGF23 maintains balance

#### Stage 3a-3b

GFR 30-59

**Normal/↑PO₄**

↑↑FGF23, ↑PTH

#### Stage 4

GFR 15-29

**↑PO₄ Common**

Maximal FGF23/PTH

#### Stage 5

GFR \<15

**↑↑PO₄**

Requires binders/dialysis

## 💀 Complications of Hyperphosphatemia

### Vascular Calcification

- Medial arterial calcification
- Coronary artery disease
- Valvular calcification
- ↑Pulse pressure, LVH
- Major cause of CV death in CKD

### CKD-MBD

- Secondary hyperparathyroidism
- Adynamic bone disease
- Osteitis fibrosa cystica
- Mixed uremic osteodystrophy
- Fractures, bone pain

### Soft Tissue Calcification

- Corneal/conjunctival deposits
- Periarticular calcification
- Skin (pruritus)
- Visceral organs
- Calciphylaxis (rare, fatal)

## 🔬 Etiology and Pathophysiology

### Decreased Excretion (Most Common)

- **CKD:** Primary cause (90% of cases)
- **AKI:** Sudden loss of filtration
- **Hypoparathyroidism:** ↓PTH → ↓PO₄ excretion
- **Pseudohypoparathyroidism:** PTH resistance
- **Acromegaly:** ↑GH → ↑PO₄ reabsorption

### Increased Load

- **Tumor Lysis Syndrome:** Massive cell death
- **Rhabdomyolysis:** Muscle breakdown
- **Hemolysis:** RBC phosphate release
- **Exogenous:** Phosphate enemas, IV phosphate
- **Vitamin D intoxication:** ↑Absorption

### Transcellular Shifts

- **Metabolic acidosis:** H⁺/PO₄ exchange
- **Respiratory acidosis:** Cell efflux
- **DKA treatment:** Reveals total body depletion
- **Catabolism:** Cell breakdown

### ⚠️ Tumor Lysis Syndrome - High Risk Features

- High-grade lymphomas, acute leukemias
- High tumor burden (WBC \>100k, bulky disease)
- ↑LDH, ↑uric acid pre-treatment
- Pre-existing renal insufficiency
- Develops 12-72 hours after chemotherapy

**Prevention:** Hydration, allopurinol/rasburicase, frequent monitoring

## 🔬 Diagnostic Approach

### Evaluation Algorithm

1 **Confirm Hyperphosphatemia:** PO₄ \>4.5 mg/dL (fasting preferred) 2 **Assess Renal Function:** Creatinine, eGFR 3 **Calculate Fractional Excretion:**

- FePO₄ = (UPO₄ × SCr)/(SPO₄ × UCr) × 100
- \<5% suggests ↑reabsorption or ↓filtered load
- \>5% suggests appropriate renal response

4 **Additional Labs:**

- Calcium (often low)
- PTH (secondary hyperparathyroidism in CKD)
- 25-OH Vitamin D
- If TLS suspected: Uric acid, K⁺, LDH

## 🧮 Calcium-Phosphate Product Calculator

Serum Calcium (mg/dL): 9.0 Serum Phosphate (mg/dL): 6.5 Ca × PO₄ Product: 58.5 mg²/dL²\
**⚠️ ELEVATED - Risk of calcification!**

## 💊 Treatment Strategies

### Acute Management

1 **Enhanced Elimination (if renal function preserved):**

- IV normal saline hydration
- Loop diuretics (enhance phosphaturia)
- Limited efficacy if GFR \<30

2 **Dialysis Indications:**

- Severe hyperphosphatemia (\>10 mg/dL)
- Symptomatic hypocalcemia
- Ca × PO₄ product \>70
- Tumor lysis syndrome
- Removes 30-50 mg/dL over 4 hours

### Chronic Management in CKD

#### Step 1: Dietary Phosphate Restriction

##### HIGH Phosphate (Avoid)

- Processed foods
- Dark sodas
- Dairy products
- Organ meats
- Nuts, beans

##### MEDIUM Phosphate (Limit)

- Meat, poultry
- Fish
- Eggs
- Whole grains

##### LOW Phosphate (Prefer)

- Fresh fruits
- Vegetables
- Rice, pasta
- Bread (white)

**Goal:** 800-1000 mg/day (difficult to achieve; normal diet ~1500 mg/day)

#### Step 2: Phosphate Binders

[TABLE]

#### KDIGO Recommendations

- Restrict Ca-based binders if serum Ca elevated
- Limit elemental Ca from binders to 1500 mg/day
- Choose binder based on Ca, cost, pill burden
- Target PO₄ toward normal range (not strict targets)
- Monitor Ca, PO₄ monthly initially, then q3 months

### Novel Therapies

### Tenapanor

- NHE3 inhibitor
- ↓Paracellular PO₄ absorption
- Add-on therapy
- Main side effect: diarrhea

### Nicotinamide

- Inhibits NaPi cotransporters
- ↓Intestinal PO₄ absorption
- Under investigation
- May cause thrombocytopenia

## 🎯 Key Clinical Pearls

- Phosphate rises late in CKD - FGF23 and PTH compensate until GFR \<30
- Ca × PO₄ product \>55 → vascular calcification risk; \>70 → critical
- Each 1 mg/dL ↑PO₄ → 18-35% ↑mortality in dialysis patients
- Dietary restriction alone rarely sufficient - binders usually needed
- "Hidden" phosphate in processed foods (additives) - 100% absorbed
- Natural phosphate (meat, dairy) - only 40-60% absorbed
- Take binders WITH meals - ineffective if taken separately
- Avoid Ca-based binders if Ca \>10.2 or on active vitamin D
- Aluminum binders: Potent but toxic - max 4 weeks in severe cases
- Dialysis removes ~800 mg per session (3×/week = 2400 mg/week)
- Normal dietary intake ~1500 mg/day = 10,500 mg/week (net positive balance)
- Check phosphate fasting - can rise 1-2 mg/dL postprandially

## 📚 Special Populations

### Dialysis Patients

- Target PO₄ 3.5-5.5 mg/dL (KDIGO)
- Requires binders + dietary restriction
- Adjust binders based on meals
- Consider dialysate PO₄ concentration
- Monitor monthly

### Kidney Transplant

- PO₄ often normalizes post-transplant
- May have transient hypophosphatemia
- Persistent ↑PO₄ suggests graft dysfunction
- Wean binders carefully

### Pediatric CKD

- Growth concerns with restriction
- Balance PO₄ control with nutrition
- Age-specific normal ranges
- Monitor growth parameters


---

[Website version](https://urinenephrology.org/2025_UDPA_Lectures_Live/electrolytes/phosphorus/hyperphosphatemia.html) · Markdown synchronized October 3, 2026.